ArticleMicroplastics and nanoplastics2025
Advancing pyrolysis-gas chromatography-mass spectrometry for the accurate quantification of micro- and nanoplastics in human blood.
Article in Microplastics and nanoplastics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Micro- and Nanoplastics in Cardiovascular Toxicology: Human Tissue Detection, Clinical Phenotypes, and Adverse Outcome Signals.Cardiovascular toxicology · 2026Review
- Micro- and Nanoplastics as Emerging Drivers of Liver Injury: Exposure, Evidence, and Mechanisms.International journal of molecular sciences · 2026Review
- Reduction in Circulating Microplastics in Humans Following Gastrointestinal Sequestration by Chitosan: A Pilot Controlled Study.Journal of xenobiotics · 2026Article
- Emerging cardiovascular risks of micro- and nanoplastics: toxic effects and mechanistic pathways.Particle and fibre toxicology · 2026Review
- Role of atomic force microscopy in characterization of heterotypic cancer spheroids and their interaction with microplastic particles.Scientific reports · 2026Article
- Microplastics and neurotoxicity: could prenatal exposure to microplastics boost congenital enteric neuropathies?Frontiers in toxicology · 2026Review
- The Plasticene Paradigm: Microplastics, Gut Dysbiosis, and Food Allergy - A Critical Commentary.Journal of asthma and allergy · 2026Review
- Micro- and nanoplastic exposure, immune cell activation, and lung function in young adults.Microplastics and nanoplastics · 2026Article
- Polystyrene and polyethylene terephthalate nanoplastics differentially impact mouse ovarian follicle function.Environmental pollution (Barking, Essex : 1987) · 2025Article
- Polystyrene and polyethylene terephthalate nanoplastics differentially impact mouse ovarian follicle function.bioRxiv : the preprint server for biology · 2025Article
- Elevated Micro- and Nanoplastics Detected in Preterm Human Placentae.Research square · 2025Article
- Microplastic particles in human blood and their association with coagulation markers.Scientific reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Quantification of micro- and nanoplastics (MNPs) in human samples is essential for accurately assessing human exposure and understanding the potential health impacts of these pervasive pollutants. Blood plays a key role in revealing potential MNPs exposure and its health impacts. The detection of MNPs in human blood, however, is analytically challenging due to the complex composition of the sample and the limited availability of sensitive analytical methods. Pyrolysis-gas chromatography-mass spectrometry (Py-GC-MS) using Selected Ion Monitoring (SIM) has been widely used to quantify MNPs in human blood. In this work the analytical approach was improved by employing full scan data acquisition. The mass concentration of six polymers widely used in plastic materials - poly(methyl methacrylate) (PMMA), polypropylene (PP), polystyrene (PS), polyethylene (PE), polyvinyl chloride (PVC), and polyethylene terephthalate (PET) - was determined in 102 human whole blood samples. Rigorous QA/QC measures were established which are essential for ensuring the reliability and accuracy of the method. Limits of detection (LODs) ranged from 14 ng/mL (PP) to 245 ng/mL (PE). The recoveries of the quantitation compounds ranged from 52 to 102%. MNPs were detected in all the samples investigated with PVC as the most frequently detected polymer (99% of all samples). For 20% of samples, the concentration was above the limit of quantification (LOQ) with an average total concentration of 386 ng/mL. The analysis of MNPs in human blood is relevant for future research to understand the pathways of MNP absorption, accumulation, and potential health risks associated with exposure to plastic pollutants. The use of full scan data acquisition enabled simultaneous ion monitoring allowing for more careful selection of quantitation compounds and provides the potential for retrospective data analysis. Supplementary Information: The online version contains supplementary material available at 10.1186/s43591-025-00152-7.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.